Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:23:53.290Z.
Calculation as of: 2026-10-06T21:23:53.290Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 49ccfc7bc81d1e6c211e00ba0f17dd71ad394db50a55f8cf6fe3d6b4e4d88636
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$1.71B
Free Cash Flow Yield
8.38%
TTM Avg
4.66%
3Y Avg
5.81%
5Y Avg
5.68%
Market Cap
$1.73B
Free Cash Flow Yield
N/A
TTM Avg
8.65%
3Y Avg
8.65%
5Y Avg
8.65%
Market Cap
$1.74B
Free Cash Flow Yield
N/A
TTM Avg
0.77%
3Y Avg
2.10%
5Y Avg
2.10%
Market Cap
$1.74B
Free Cash Flow Yield
3.19%
TTM Avg
2.49%
3Y Avg
2.49%
5Y Avg
2.49%
Market Cap
$1.75B
Free Cash Flow Yield
10.70%
TTM Avg
10.17%
3Y Avg
6.99%
5Y Avg
4.97%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zenas BioPharma, Inc. (ZBIO) | $1.70B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 8.38% | 4.66% | 5.81% | 5.68% |
| Personalis, Inc. (PSNL)vs › | $1.71B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | N/A | 8.65% | 8.65% | 8.65% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | N/A | 0.77% | 2.10% | 2.10% |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | 3.19% | 2.49% | 2.49% | 2.49% |
| Absci Corporation (ABSI)vs › | $1.74B | N/A | N/A | N/A | N/A |
| Novocure Ltd (NVCR)vs › | $1.74B | N/A | 0.29% | 0.49% | 0.42% |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 10.70% | 10.17% | 6.99% | 4.97% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
